Elliot from Sweden

Registered at the short selling broker eToro, 5 minutes ago.

» Try eToro you too
75% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

XBiotech, Inc. (XBIT) shares information

XBiotech, Inc.

24h Change

0.49 %


Live rate: Market closed

Stock data per Wednesday 25 Nov, 2020

0.09 (+ 0.49%)
US Market is closed

Live Stock price in graph for XBiotech, Inc. (XBIT)

  • Latest Volume

    98,497 (-5.2 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    18.57 USD

  • Today low

    17.9 USD

  • 52 week high

    26.4 USD

  • 52 week low

    8.72 USD

  • YTD Change


Quick links

Price target by analysts

The 1 latest analyst estimates, per Monday 6 April, 2020, show the following high, low and average price targets.
Target Average: 18 USD
Target High: 18 USD
Target Low: 18 USD


Latest news about XBiotech, Inc.

Below you can find the most recent news posts about XBiotech, Inc., primarily from US and UK based news sources.

XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall

Monday, 24 August 2020, 22:27:51
Stocks that moved heavily or traded substantially Monday: XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall
— ABC News

XBiotech Discovers COVID-19 Candidate Therapy

Monday, 17 August 2020, 14:20:00
The Company has Identified Highly Targeted Anti-COVID-19 True Human Antibodies from Immune Donor Blood
— GlobeNewswire

XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy

Wednesday, 22 July 2020, 15:20:00
After Sale of its Previous Anti-IL-1a True Human Antibody, Company Now Has Production Cell to Manufacture New Molecule for Launch of Clinical Studies in 2021
— GlobeNewswire

XBiotech antibody shows potential for treating stroke-related brain injury (NASDAQ:XBIT)

Tuesday, 14 July 2020, 16:32:18
XBiotech (XBIT +2.6%) announces encouraging results from research conducted in Switzerland that supports the rationale of interleukin-1 alpha (IL-1⍺) block
— Seeking Alpha

XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke

Tuesday, 14 July 2020, 15:25:00
Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy
— GlobeNewswire

Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €200
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have XBIT available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.